Riskpilot← Back to searchSign inGet full accessSapphire Bioscience Holding ApS
APSActiveCVR 38599917Industriparken 39Activities of holding companies · NACE 6421Est. 2017— employees
Revenue 2024
DKK -175K
+257% vs 2023
EBITDA margin
100.0%
-257% vs 2023
Equity ratio
92.4%
Financial strength
Net profit 2024
DKK 38,8M
+38% vs 2023
| Revenue | DKK -175K | +257% |
| EBITDA | DKK -175K | -257% |
| Net profit | DKK 38,8M | +38% |
| Total assets | DKK 195,7M | +22% |
| Equity | DKK 180,7M | +17% |
| Employees | — | — |
Legal name
Sapphire Bioscience Holding ApS
CVR number
38599917
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
27. april 2017
Share capital
DKK 15.877.635
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at udøve virksomhed med handel, service og investering og hermed naturligt beslægtet virksomhed efter direktionens skøn.
Address
Industriparken 39
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -38 | -62 | -37 | -28 | -12 | -64 | -49 | -175 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -38 | -62 | -37 | -28 | -12 | -64 | -49 | -175 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -38 | -62 | -37 | -28 | -12 | -64 | -49 | -175 |
| Net financials | 54.150 | 39.990 | 22.621 | 25.077 | 35.838 | 43.796 | 28.113 | 38.798 |
| Profit before tax | 54.112 | 39.929 | 22.584 | 25.049 | 35.826 | 43.732 | 28.064 | 38.623 |
| Tax | -143 | -75 | -4 | -11 | 1 | -10 | 42 | -170 |
| Net profit | 54.255 | 40.004 | 22.588 | 25.059 | 35.825 | 43.742 | 28.022 | 38.793 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 101.654 | 98.591 | 101.484 | 115.574 | 155.438 | 223.917 | 160.722 | 195.655 |
| Equity | 75.822 | 98.450 | 101.310 | 107.468 | 144.331 | 188.957 | 154.312 | 180.715 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25.832 | 141 | 174 | 8.105 | 11.107 | 34.960 | 6.410 | 14.940 |
| Total debt | 25.832 | 141 | 174 | 8.105 | 11.107 | 34.960 | 6.410 | 14.940 |
EBITDA margin
-17500000.0%
This company
15.8%
Market median
-110759594% vs market
20172024
Equity ratio
92.4%
This company
38.2%
Market median
+142% vs market
20172024
Return on equity
21.5%
This company
18.4%
Market median
+17% vs market
20172024
Net profit margin
3879300000.0%
This company
8.1%
Market median
+47892592493% vs market
20172024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-04-27 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MK Management | Management | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.7% | 66.7% | 2022 | |
TTJ Invest Holding ApS | Company | 25.0% | 25.0% | 2021 |
| Individual | 10.0% | 10.0% | 2017 | |
GINSBORG HOLDING ApS | Company | 5.0% | 5.0% | 2017 |
RMP HOLDING ApS | Company | 5.0% | 5.0% | 2017 |
CAIXA INVEST ApS | Company | 5.0% | 5.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TTJ Invest Holding ApS
Sapphire Bioscience Holding ApS Board members of Sapphire Bioscience Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michel Krall Jürgens | Management | 0 companies |
| Thais Taaning Johansen | Board of Directors | 0 companies |
| Peter Max | Board of Directors | 0 companies |
| Harald Høegh | Chairman | 0 companies |
| Eirik Lauglo | Board of Directors | 0 companies |
| Gustaf Peter Reinhold von Ehrenheim | Board of Directors | 0 companies |